Optimizing Successful Development of Viral Vector Gene Therapies, Gene Therapy Trials, and Companion Diagnostics

Dec 05, 2019

Free Energy Perturbation (FEP): Another technique in the drug discovery toolbox

Dec 05, 2019

Posted by Cresset

The Role of Integrated Scientific Advice for the Early Determination of RWE Requirements in HTA and Payer Assessments

Dec 03, 2019

Perspectives on Gene Therapy: Defining and Demonstrating Value to Payers

Nov 27, 2019

2019 MassBio Industry Snapshot

Nov 26, 2019

Pragmatic Randomized Trials: Considerations for Design and Implementation

Nov 20, 2019

Delivering on the Promise of Cell Therapy: Challenges and Trends

Nov 20, 2019

Advanced Analytical Approaches for Accelerated Development of Gene Therapy Products

Nov 14, 2019

Posted by ProtaGene

From Data Chaos to Order & Insight: Creating a Connected Data Ecosystem to Drive Drug Development

Nov 14, 2019

What Do Value Assessments Miss?

Nov 14, 2019